The Market Reports

Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com

Global Asthma Therapeutics Market Research Report 2024

Global Asthma Therapeutics Market Research Report 2024

Publishing Date : Jan, 2024

License Type :
 

Report Code : 1885014

No of Pages : 90

Ask Your Query

The global Asthma Therapeutics market was valued at US$ 22070 million in 2023 and is anticipated to reach US$ 27800 million by 2030, witnessing a CAGR of 3.3% during the forecast period 2024-2030.

The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.

This report aims to provide a comprehensive presentation of the global market for Asthma Therapeutics, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Asthma Therapeutics.

Report Scope

The Asthma Therapeutics market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Asthma Therapeutics market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided. 
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.

The report will help the Asthma Therapeutics companies, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

By Company

  •  AstraZeneca
  •  Boehringer Ingelheim
  •  F. Hoffmann-La Roche
  •  GSK
  •  Merck
  •  Horizon Pharma
  •  Mitsubishi Tanabe Pharma
  •  Sanofi
  •  Mundipharma
  •  Nycomed
  •  Kissei Pharmaceutical
  •  ALK-Abello
  •  Array BioPharma
  •  SAMA Pharmaceuticals
  •  Whanin Pharmaceutical

By Type

  • Inhalation
  • Parenteral
  • Oral

By Application

  • Hospitals
  • Clinics

Consumption by Region

  • North America (United States, Canada)
  • Europe (Germany, France, U.K., Italy, Netherlands)
  • Asia-Pacific (China, Japan, South Korea, China Taiwan, Southeast Asia, India)
  • Latin America, Middle East & Africa (Latin America, Mexico, Brazil, Turkey)

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Asthma Therapeutics companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.

 

 1 Report Overview
    1.1 Study Scope
    1.2 Market Analysis by Type
        1.2.1 Global Asthma Therapeutics Market Size Growth Rate by Type: 2019 VS 2023 VS 2030
        1.2.2 Inhalation
        1.2.3 Parenteral
        1.2.4 Oral
    1.3 Market by Application
        1.3.1 Global Asthma Therapeutics Market Growth by Application: 2019 VS 2023 VS 2030
        1.3.2 Hospitals
        1.3.3 Clinics
    1.4 Study Objectives
    1.5 Years Considered
    1.6 Years Considered

 2 Global Growth Trends
    2.1 Global Asthma Therapeutics Market Perspective (2019-2030)
    2.2 Asthma Therapeutics Growth Trends by Region
        2.2.1 Global Asthma Therapeutics Market Size by Region: 2019 VS 2023 VS 2030
        2.2.2 Asthma Therapeutics Historic Market Size by Region (2019-2024)
        2.2.3 Asthma Therapeutics Forecasted Market Size by Region (2025-2030)
    2.3 Asthma Therapeutics Market Dynamics
        2.3.1 Asthma Therapeutics Industry Trends
        2.3.2 Asthma Therapeutics Market Drivers
        2.3.3 Asthma Therapeutics Market Challenges
        2.3.4 Asthma Therapeutics Market Restraints

 3 Competition Landscape by Key Players
    3.1 Global Top Asthma Therapeutics Players by Revenue
        3.1.1 Global Top Asthma Therapeutics Players by Revenue (2019-2024)
        3.1.2 Global Asthma Therapeutics Revenue Market Share by Players (2019-2024)
    3.2 Global Asthma Therapeutics Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
    3.3 Players Covered: Ranking by Asthma Therapeutics Revenue
    3.4 Global Asthma Therapeutics Market Concentration Ratio
        3.4.1 Global Asthma Therapeutics Market Concentration Ratio (CR5 and HHI)
        3.4.2 Global Top 10 and Top 5 Companies by Asthma Therapeutics Revenue in 2023
    3.5 Asthma Therapeutics Key Players Head office and Area Served
    3.6 Key Players Asthma Therapeutics Product Solution and Service
    3.7 Date of Enter into Asthma Therapeutics Market
    3.8 Mergers & Acquisitions, Expansion Plans

 4 Asthma Therapeutics Breakdown Data by Type
    4.1 Global Asthma Therapeutics Historic Market Size by Type (2019-2024)
    4.2 Global Asthma Therapeutics Forecasted Market Size by Type (2025-2030)

 5 Asthma Therapeutics Breakdown Data by Application
    5.1 Global Asthma Therapeutics Historic Market Size by Application (2019-2024)
    5.2 Global Asthma Therapeutics Forecasted Market Size by Application (2025-2030)

 6 North America
    6.1 North America Asthma Therapeutics Market Size (2019-2030)
    6.2 North America Asthma Therapeutics Market Growth Rate by Country: 2019 VS 2023 VS 2030
    6.3 North America Asthma Therapeutics Market Size by Country (2019-2024)
    6.4 North America Asthma Therapeutics Market Size by Country (2025-2030)
    6.5 United States
    6.6 Canada

 7 Europe
    7.1 Europe Asthma Therapeutics Market Size (2019-2030)
    7.2 Europe Asthma Therapeutics Market Growth Rate by Country: 2019 VS 2023 VS 2030
    7.3 Europe Asthma Therapeutics Market Size by Country (2019-2024)
    7.4 Europe Asthma Therapeutics Market Size by Country (2025-2030)
    7.5 Germany
    7.6 France
    7.7 U.K.
    7.8 Italy
    7.9 Russia
    7.10 Nordic Countries

 8 Asia-Pacific
    8.1 Asia-Pacific Asthma Therapeutics Market Size (2019-2030)
    8.2 Asia-Pacific Asthma Therapeutics Market Growth Rate by Region: 2019 VS 2023 VS 2030
    8.3 Asia-Pacific Asthma Therapeutics Market Size by Region (2019-2024)
    8.4 Asia-Pacific Asthma Therapeutics Market Size by Region (2025-2030)
    8.5 China
    8.6 Japan
    8.7 South Korea
    8.8 Southeast Asia
    8.9 India
    8.10 Australia

 9 Latin America
    9.1 Latin America Asthma Therapeutics Market Size (2019-2030)
    9.2 Latin America Asthma Therapeutics Market Growth Rate by Country: 2019 VS 2023 VS 2030
    9.3 Latin America Asthma Therapeutics Market Size by Country (2019-2024)
    9.4 Latin America Asthma Therapeutics Market Size by Country (2025-2030)
    9.5 Mexico
    9.6 Brazil

 10 Middle East & Africa
    10.1 Middle East & Africa Asthma Therapeutics Market Size (2019-2030)
    10.2 Middle East & Africa Asthma Therapeutics Market Growth Rate by Country: 2019 VS 2023 VS 2030
    10.3 Middle East & Africa Asthma Therapeutics Market Size by Country (2019-2024)
    10.4 Middle East & Africa Asthma Therapeutics Market Size by Country (2025-2030)
    10.5 Turkey
    10.6 Saudi Arabia
    10.7 UAE

 11 Key Players Profiles
    11.1 AstraZeneca
        11.1.1 AstraZeneca Company Detail
        11.1.2 AstraZeneca Business Overview
        11.1.3 AstraZeneca Asthma Therapeutics Introduction
        11.1.4 AstraZeneca Revenue in Asthma Therapeutics Business (2019-2024)
        11.1.5 AstraZeneca Recent Development
    11.2 Boehringer Ingelheim
        11.2.1 Boehringer Ingelheim Company Detail
        11.2.2 Boehringer Ingelheim Business Overview
        11.2.3 Boehringer Ingelheim Asthma Therapeutics Introduction
        11.2.4 Boehringer Ingelheim Revenue in Asthma Therapeutics Business (2019-2024)
        11.2.5 Boehringer Ingelheim Recent Development
    11.3 F. Hoffmann-La Roche
        11.3.1 F. Hoffmann-La Roche Company Detail
        11.3.2 F. Hoffmann-La Roche Business Overview
        11.3.3 F. Hoffmann-La Roche Asthma Therapeutics Introduction
        11.3.4 F. Hoffmann-La Roche Revenue in Asthma Therapeutics Business (2019-2024)
        11.3.5 F. Hoffmann-La Roche Recent Development
    11.4 GSK
        11.4.1 GSK Company Detail
        11.4.2 GSK Business Overview
        11.4.3 GSK Asthma Therapeutics Introduction
        11.4.4 GSK Revenue in Asthma Therapeutics Business (2019-2024)
        11.4.5 GSK Recent Development
    11.5 Merck
        11.5.1 Merck Company Detail
        11.5.2 Merck Business Overview
        11.5.3 Merck Asthma Therapeutics Introduction
        11.5.4 Merck Revenue in Asthma Therapeutics Business (2019-2024)
        11.5.5 Merck Recent Development
    11.6 Horizon Pharma
        11.6.1 Horizon Pharma Company Detail
        11.6.2 Horizon Pharma Business Overview
        11.6.3 Horizon Pharma Asthma Therapeutics Introduction
        11.6.4 Horizon Pharma Revenue in Asthma Therapeutics Business (2019-2024)
        11.6.5 Horizon Pharma Recent Development
    11.7 Mitsubishi Tanabe Pharma
        11.7.1 Mitsubishi Tanabe Pharma Company Detail
        11.7.2 Mitsubishi Tanabe Pharma Business Overview
        11.7.3 Mitsubishi Tanabe Pharma Asthma Therapeutics Introduction
        11.7.4 Mitsubishi Tanabe Pharma Revenue in Asthma Therapeutics Business (2019-2024)
        11.7.5 Mitsubishi Tanabe Pharma Recent Development
    11.8 Sanofi
        11.8.1 Sanofi Company Detail
        11.8.2 Sanofi Business Overview
        11.8.3 Sanofi Asthma Therapeutics Introduction
        11.8.4 Sanofi Revenue in Asthma Therapeutics Business (2019-2024)
        11.8.5 Sanofi Recent Development
    11.9 Mundipharma
        11.9.1 Mundipharma Company Detail
        11.9.2 Mundipharma Business Overview
        11.9.3 Mundipharma Asthma Therapeutics Introduction
        11.9.4 Mundipharma Revenue in Asthma Therapeutics Business (2019-2024)
        11.9.5 Mundipharma Recent Development
    11.10 Nycomed
        11.10.1 Nycomed Company Detail
        11.10.2 Nycomed Business Overview
        11.10.3 Nycomed Asthma Therapeutics Introduction
        11.10.4 Nycomed Revenue in Asthma Therapeutics Business (2019-2024)
        11.10.5 Nycomed Recent Development
    11.11 Kissei Pharmaceutical
        11.11.1 Kissei Pharmaceutical Company Detail
        11.11.2 Kissei Pharmaceutical Business Overview
        11.11.3 Kissei Pharmaceutical Asthma Therapeutics Introduction
        11.11.4 Kissei Pharmaceutical Revenue in Asthma Therapeutics Business (2019-2024)
        11.11.5 Kissei Pharmaceutical Recent Development
    11.12 ALK-Abello
        11.12.1 ALK-Abello Company Detail
        11.12.2 ALK-Abello Business Overview
        11.12.3 ALK-Abello Asthma Therapeutics Introduction
        11.12.4 ALK-Abello Revenue in Asthma Therapeutics Business (2019-2024)
        11.12.5 ALK-Abello Recent Development
    11.13 Array BioPharma
        11.13.1 Array BioPharma Company Detail
        11.13.2 Array BioPharma Business Overview
        11.13.3 Array BioPharma Asthma Therapeutics Introduction
        11.13.4 Array BioPharma Revenue in Asthma Therapeutics Business (2019-2024)
        11.13.5 Array BioPharma Recent Development
    11.14 SAMA Pharmaceuticals
        11.14.1 SAMA Pharmaceuticals Company Detail
        11.14.2 SAMA Pharmaceuticals Business Overview
        11.14.3 SAMA Pharmaceuticals Asthma Therapeutics Introduction
        11.14.4 SAMA Pharmaceuticals Revenue in Asthma Therapeutics Business (2019-2024)
        11.14.5 SAMA Pharmaceuticals Recent Development
    11.15 Whanin Pharmaceutical
        11.15.1 Whanin Pharmaceutical Company Detail
        11.15.2 Whanin Pharmaceutical Business Overview
        11.15.3 Whanin Pharmaceutical Asthma Therapeutics Introduction
        11.15.4 Whanin Pharmaceutical Revenue in Asthma Therapeutics Business (2019-2024)
        11.15.5 Whanin Pharmaceutical Recent Development

 12 Analyst's Viewpoints/Conclusions

 13 Appendix
    13.1 Research Methodology
        13.1.1 Methodology/Research Approach
        13.1.2 Data Source
    13.2 Disclaimer
    13.3 Author Details

Published By : QY Research

Why ‘The Market Reports’

In Business: Pre Sales Support: Post Sales Support: Turn Around Time: Clients Served: Clients Assisted: Client Types: Payment: Partners with: Number of reports: Custom Research: Report Availability: Report Delivery Format: Security:

Payments Accepted From

Connect with us at

Complete Secure Website

SiteLock